Lídia Maria Magalhães de Rezende

Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis

Marcela Cristina Robaina, Luciano Mazzoccoli, Viviane Oliveira Arruda et al. · Experimental and Molecular Pathology · 2015 · 75 citations

Tumor Biology, Lymphoid Neoplasia, Disease Pathogenesis +10

Histone deacetylase inhibitor prevents cell growth in Burkitt’s lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101

Ana Carolina dos Santos Ferreira, Marcela Cristina Robaina, Lídia Maria Magalhães de Rezende et al. · Annals of Hematology · 2014 · 47 citations

Pi3k/akt Pathways, Lymphoid Neoplasia, Oncology +11

miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis

Marcela Cristina Robaina, Roberta Soares Faccion, Luciano Mazzoccoli et al. · Annals of Hematology · 2016 · 42 citations

Lymphoid Neoplasia, Oncology, Medicine +9

Circulating cell-free and Epstein–Barr virus DNA in pediatric B-non-Hodgkin lymphomas

Sandro Lemos Machado, Marcela Cristina Robaina, Lídia Maria Magalhães de Rezende et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 29 citations

Immunodeficiencies, Immunology, Pathology +16

Langerhans cell histiocytosis: Differences and similarities in long-term outcome of paediatric and adult patients at a single institutional centre

Raquel Ciuvalschi Maia, Lídia Maria Magalhães de Rezende, Marcela Cristina Robaina et al. · Hematology · 2014 · 25 citations · Full text